Deals Orthocell considers IPO push Biotech player Orthocell has appointed two financial advisory firms to seek out investors as part of the company's plans to go public. 20 May 2014
Deals NZ biotech chooses Australia for IPO Perth based stockbroking firm Patersons Securities is punting on investors' emerging appetite for biotech stocks, agreeing to underwrite New Zealand biopharmaceutical company Innate Immunotherapeutics's $16.5 million initial public offering. 16 Oct 2013
